Cargando…

Antidepressant-Associated Treatment Emergent Mania: A Meta-Analysis to Guide Risk Modeling Pharmacogenomic Targets of Potential Clinical Value

BACKGROUND: The purpose of this study was to review the association between the SLC6A4 5-HTTLPR polymorphism and antidepressant (AD)-associated treatment emergent mania (TEM) in bipolar disorder alongside starting a discussion on the merits of developing risk stratification models to guide when not...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nuñez, Nicolas A., Coombes, Brandon J., Melhuish Beaupre, Lindsay, Romo-Nava, Francisco, Gardea-Resendez, Manuel, Ozerdem, Aysegul, Veldic, Marin, Singh, Balwinder, Sanchez Ruiz, Jorge A., Cuellar-Barboza, Alfredo, Leung, Jonathan G., Prieto, Miguel L., McElroy, Susan L., Biernacka, Joanna M., Frye, Mark A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476595/ https://www.ncbi.nlm.nih.gov/pubmed/37683232 http://dx.doi.org/10.1097/JCP.0000000000001747

Ejemplares similares

Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania
por: Gardea-Resendez, Manuel, et al.
Publicado: (2022)

Clinical and Genetic Correlates of Bipolar Disorder With Childhood-Onset Attention Deficit Disorder
por: Nunez, Nicolas A., et al.
Publicado: (2022)

Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection
por: Cuéllar-Barboza, Alfredo B., et al.
Publicado: (2020)

Long-Term Lithium Therapy and Thyroid Disorders in Bipolar Disorder: A Historical Cohort Study
por: Joseph, Boney, et al.
Publicado: (2023)

Racial differences in pathways to care preceding first episode mania or psychosis: a historical cohort prodromal study
por: Gardea-Resendez, Manuel, et al.
Publicado: (2023)

Editorial: Neurobiological Underpinnings of Bipolar Disorder and Its Treatment
por: Singh, Balwinder, et al.
Publicado: (2021)

Association of schizophrenia polygenic risk score with manic and depressive psychosis in bipolar disorder
por: Markota, Matej, et al.
Publicado: (2018)

Leveraging electronic health records to study pleiotropic effects on bipolar disorder and medical comorbidities
por: Prieto, M L, et al.
Publicado: (2016)

Dissecting the Epigenetic Changes Induced by Non-Antipsychotic Mood Stabilizers on Schizophrenia and Affective Disorders: A Systematic Review
por: Gardea-Resendez, Manuel, et al.
Publicado: (2020)

Pharmacogenomics‐Driven Prediction of Antidepressant Treatment Outcomes: A Machine‐Learning Approach With Multi‐trial Replication
por: Athreya, Arjun P., et al.
Publicado: (2019)

Pharmacogenomics in depression and antidepressants
por: Bondy, Brigitta
Publicado: (2005)

Antidepressant-withdrawal mania - a case report
por: Magalhães, M., et al.
Publicado: (2021)

Differential Dorsolateral Prefrontal Cortex Proteomic Profiles of Suicide Victims with Mood Disorders
por: Cabello-Arreola, Alejandra, et al.
Publicado: (2020)

Antidepressant Induced Mania : Is it a risk factor for Antidepressant Abuse?
por: Ramesh, S., et al.
Publicado: (2003)

Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses
por: Frye, Mark A, et al.
Publicado: (2015)

Athanasios Koukopoulos’ Psychiatry: The Primacy of Mania and the Limits of Antidepressants
por: Ghaemi, S. Nassir, et al.
Publicado: (2017)

Pharmacogenomics of antidepressant treatment effects
por: Licinio, Julio, et al.
Publicado: (2011)

MULTIFOCAL LEUCOENCEPHALOPATHY PRESENTING AS ANTIDEPRESSANT INDUCED MANIA
por: Damodaran, Saji S., et al.
Publicado: (1994)

Antidepressant-induced mania in obsessive compulsive disorder
por: Philip, Johann, et al.
Publicado: (2012)

Pharmacogenomic strategy for individualizing antidepressant therapy
por: Lin, Keh-Ming, et al.
Publicado: (2008)

Bipolar disorder with binge eating behavior: a genome-wide association study implicates PRR5-ARHGAP8
por: McElroy, Susan L., et al.
Publicado: (2018)

Terbinafine and antidepressants: Potential risk of medication induced mania
por: Barbosa, P., et al.
Publicado: (2021)

Antidepressant discontinuation manias: a new bipolar subtype?
por: Abou Kassm, S., et al.
Publicado: (2022)

Mood‐Stabilizing Antiepileptic Treatment Response in Bipolar Disorder: A Genome‐Wide Association Study
por: Ho, Ada Man‐Choi, et al.
Publicado: (2020)

Differential SLC1A2 Promoter Methylation in Bipolar Disorder With or Without Addiction
por: Jia, Yun-Fang, et al.
Publicado: (2017)

Mania and bipolar depression: complementing not opposing poles—a post-hoc analysis of mixed features in manic and hypomanic episodes
por: Born, Christoph, et al.
Publicado: (2021)

Mixed mania associated with cessation of breastfeeding
por: Schmidt, Kristen A., et al.
Publicado: (2016)

Pharmacogenomics: A focus on antidepressants and atypical antipsychotics
por: Lister, Jonathan F.
Publicado: (2016)

Pharmacogenomic testing and antidepressant response: problems and promises
por: Smith, Tawny L., et al.
Publicado: (2020)

Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments
por: Lin, Eugene, et al.
Publicado: (2021)

Statistical methods for testing X chromosome variant associations: application to sex-specific characteristics of bipolar disorder
por: Jons, William A., et al.
Publicado: (2019)

The Role of Base Excision Repair in Major Depressive Disorder and Bipolar Disorder
por: Kucuker, M., et al.
Publicado: (2022)

Efficacy and Safety of Clonidine in the Treatment of Acute Mania in Bipolar Disorder: A Systematic Review
por: Singal, Prakamya, et al.
Publicado: (2023)

Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosing
por: Bishop, Jeffrey R.
Publicado: (2021)

Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
por: Correia, Catarina, et al.
Publicado: (2022)

Label-free proteomics differences in the dorsolateral prefrontal cortex between bipolar disorder patients with and without psychosis
por: Ho, Ada M.-C., et al.
Publicado: (2020)

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
por: Biernacka, J M, et al.
Publicado: (2015)

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
por: Biernacka, J M, et al.
Publicado: (2016)

Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores
por: Coombes, Brandon J., et al.
Publicado: (2020)

Current clinical evidence on pioglitazone pharmacogenomics
por: Kawaguchi-Suzuki, Marina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2jc1qttcvemt9vr7qp2eq1hfqj